与单独化疗相比，化疗中添加阿米万他单抗和拉泽替尼可使进展或死亡风险降低H002 is usually a precision therapeutic candidate to the procedure of NSCLC, with wide spectrum and superior selectivity towards many EGFR mutations which include These with EGFR C797S mutation.Of course, there are actually many types and styles